CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

Stock selection in the financials, consumer discretionary, communication services and information technology sectors drove ...

Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” fourth quarter 2024 investor ...

Centene’s results buoyed investors after other insurance companies reported out-of-control costs for the quarter.

Equities research analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for The Cigna Group in a ...

The holding company for Territorial Savings Bank posted revenue of $18.7 million in the period. Its revenue net of interest expense was $8 million, beating Street forecasts. For the year, the company ...

Cigna's actual EPS of $6.64 for Q4 fell short of the forecasted $7.79, representing a 14.7% miss. However, revenue of $65.65 billion surpassed expectations by 3.9%, indicating strong top-line ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

Oppenheimer lowered the firm’s price target on Cigna (CI) to $375 from $400 and keeps an Outperform rating on the shares. The firm notes ...

Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company’s stock reacted negatively in ...